IOP Inc.

New findings from A. Ergin and co-authors describe advances in cardiovascular.
Blood Weekly; 12/24/2009; 837 words; ...treatment was ended due to insufficient intraocular pressure (IOP) and systemic or local side effects. The treatment then switched...Pharmacology and Therapeutics can be contacted at: Mary Ann Liebert Inc., 140 Huguenot Street, 3RD FL, New Rochelle, NY 10801...

Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema.
PR Newswire; 12/23/2009; 1880 words; ATLANTA, Dec. 23 /PRNewswire/ -- Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes...for all patients treated in the study. Intraocular pressure (IOP) increases of 30 millimeters of mercury (mmHg) or greater...

New glaucoma study findings recently were reported by M. Tsuda and co-researchers.(Report)
Biotech Week; 12/23/2009; 792 words; ...administration was effective in reducing IOP over a 5-year period in a range...Therapeutics (Intraocular Pressure (IOP) Reduction by Latanoprost in...Period Stratified by Presenting IOP. Journal of Ocular Pharmacology...Therapeutics is: Mary Ann Liebert Inc., 140 Huguenot Street, 3RD...

Recent findings from University of Illinois highlight research in glaucoma.
Biotech Week; 12/23/2009; 854 words; ...year follow-up. Mean baseline IOP was 32.3 mmHg (+/- 14...month follow-up, the mean IOP was 18.28 mmHg (+/- 10...preservation of open angle and IOP control in eyes receiving bevacizumab...contacted at: Mary Ann Liebert Inc., 140 Huguenot Street, 3RD...

New findings reported from T. Schlote and co-authors describe advances in glaucoma.
Biotech Week; 12/23/2009; 798 words; ...thinning and the initial CCT but not between corneal thinning and IOP reductions. Topical therapy with the prostaglandin derivate...Pharmacology and Therapeutics can be contacted at: Mary Ann Liebert Inc., 140 Huguenot Street, 3RD FL, New Rochelle, NY 10801...